Clinical Trials Directory

Trials / Completed

CompletedNCT00890799

Transcatheter Closure Versus Surgery of Perimembranous Ventricular Septal Defects

Clinical Evaluation of Transcatheter Closure and Surgery of Perimembranous Ventricular Septal Defects

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
200 (actual)
Sponsor
Xijing Hospital · Academic / Other
Sex
All
Age
2 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to investigate effectiveness and safety of transcatheter closure of perimembranous ventricular septal defects.

Detailed description

Perimembranous Ventricular septal defect (VSD) is the most common congenital cardiac malformation and constitutes over 20% of all congenital cardiac disease. Though conventional surgery for VSD is a widely accepted procedure with minimal operative mortality, it carries a small but definite risk of morbidity and mortality associated with cardiopulmonary bypass and surgical closure. The newly appeared transcatheter device closure technique provides an alternative to surgical closure. However, the mid-to-long term effects of this technique using occluders is not clear. The aim of this study was to evaluate the safety and effectiveness of transcatheter closure of perimembranous ventricular septal defects using septal occluders.

Conditions

Interventions

TypeNameDescription
DEVICEShanghai pmVSD occluderVentricular Septal Defects Occluders with sizes from 4mm to 20mm.
PROCEDUREsurgeryPatient in this group received open surgical repair of pmVSD.

Timeline

Start date
2007-06-01
Primary completion
2010-12-01
Completion
2012-07-01
First posted
2009-04-30
Last updated
2013-02-05

Source: ClinicalTrials.gov record NCT00890799. Inclusion in this directory is not an endorsement.